VABOMERE (The Medicines Company)


Welcome to the PulseAid listing for the VABOMERE drug offered from The Medicines Company. This beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA],Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: The Medicines Company
NON-PROPRIETARY NAME: Meropenem-Vaborbactam
SUBSTANCE NAME: VABORBACTAM; MEROPENEM
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA],Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-10-02
END MARKETING DATE: 0000-00-00


VABOMERE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionVABOMERE from The Medicines Company
LABELER NAME: The Medicines Company
DEA SCHEDULE:
ACTIVE STRENGTH: 1; 1(g/2g; g/2g)
START MARKETING DATE: 2017-10-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 65293-009_580db23f-c656-3049-e053-2a91aa0ad616
PRODUCT NDC: 65293-009
APPLICATION NUMBER: NDA209776

Other VABORBACTAM; MEROPENEM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
The Medicines CompanyVABOMERE